Cullen/Frost Bankers’s BioLife Solutions BLFS Stock Holding History

Cullen/Frost Bankers’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$141	Sell	5 -938	-99%	-$21.9K	﹤0.01%	1372
2026 Q1	$18K	Buy	943 +99	+12%	+$2.19K	﹤0.01%	1006
2025 Q4	$20.4K	Buy	844 +67	+9%	+$1.75K	﹤0.01%	998
2025 Q3	$19.8K	Buy	777 +21	+3%	+$498	﹤0.01%	946
2025 Q2	$16.3K	Buy	+756	New	+$17K	﹤0.01%	952
2021 Q4	–	Sell	-462	Closed	-$20K	–	1197
2021 Q3	$20K	Hold	462	–	–	﹤0.01%	972
2021 Q2	$21K	Buy	+462	New	+$16.3K	﹤0.01%	974

Other funds holding BLFS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

Cullen/Frost Bankers's BLFS Position: Q2 2026 in Review

Cullen/Frost Bankers reduced its BioLife Solutions (BLFS) stake by 99% in Q2 2026, selling an estimated $21.9K and leaving 5 shares worth $141. The position accounts for ﹤0.01% of the portfolio, ranked #1372.

Cullen/Frost Bankers first reported a position in BLFS in Q2 2021 and has held it in 7 quarters since. The position peaked at $21K in Q2 2021. 82 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

Cullen/Frost Bankers held 5 shares of BioLife Solutions worth $141 as of Q2 2026.
Cullen/Frost Bankers sold 938 BioLife Solutions shares in Q2 2026, an estimated $21.9K.
BioLife Solutions made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #1372 holding.
Cullen/Frost Bankers first reported a position in BioLife Solutions in Q2 2021 and has held it in 7 quarters since.
Cullen/Frost Bankers's BioLife Solutions position peaked at $21K in Q2 2021.
82 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.